Conversion from troglitazone to rosiglitazone or pioglitazone in the VA: a multicenter DUE.

MLA

Burk M, et al. “Conversion from Troglitazone to Rosiglitazone or Pioglitazone in the VA: A Multicenter DUE.” Formulary, vol. 39, no. 6, June 2004, pp. 310–14. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106625904&authtype=sso&custid=ns315887.

APA

Burk M, Morreale AP, & Cunningham F. (2004). Conversion from troglitazone to rosiglitazone or pioglitazone in the VA: a multicenter DUE. Formulary, 39(6), 310–314.

Chicago

Burk M, Morreale AP, and Cunningham F. 2004. “Conversion from Troglitazone to Rosiglitazone or Pioglitazone in the VA: A Multicenter DUE.” Formulary 39 (6): 310–14. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=106625904&authtype=sso&custid=ns315887.